Lukasz Kuncman
Overview
Explore the profile of Lukasz Kuncman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bilski M, Korab K, Orzechowska M, Ponikowska J, Cisek P, Jereczek-Fossa B, et al.
Radiol Med
. 2025 Mar;
PMID: 40080327
Purpose: The standard treatment for oligometastatic colorectal cancer includes systemic therapy, with surgery and metastasis-directed therapy as options. The optimal strategy, especially for repeat oligoprogression (rOP), remains unclear. We report...
2.
Kuncman L, Fijuth J, Tworek D, Sierko E, Cisek P, Maslowski M, et al.
BMC Cancer
. 2025 Jan;
25(1):142.
PMID: 39856583
Background: The current standard of care (SoC) for patients with extensive-disease small-cell lung cancer (ED-SCLC) is chemo-immunotherapy. The efficacy of radiotherapy (RT) for chest consolidation has been established for patients...
3.
Loga K, Wojcik B, Stanislawek A, Papis-Ubych A, Kuncman L, Fijuth J, et al.
Rep Pract Oncol Radiother
. 2025 Jan;
29(5):558-565.
PMID: 39759555
Background: In small cell lung cancer (SCLC), limiting the radiation dose in the hippocampus area during preventive cranial irradiation (PCI) can reduce nerve injury and cognitive decline. This study was...
4.
Bilski M, Ciesielka M, Orzechowska M, Jarosz B, Calka P, Bilska S, et al.
Sci Rep
. 2024 Nov;
14(1):29345.
PMID: 39592656
Gliomas are the predominant cause of cancer-related deaths among the young population. Even after incorporation of IDH1/2 mutations and 1p19q codeletion there are doubts regarding adjuvant treatment in WHO G2/G3...
5.
Bilski M, Peszynska-Piorun M, Konat-Baska K, Brzozowska A, Korab K, Wojtyna E, et al.
Front Oncol
. 2024 Nov;
14:1478872.
PMID: 39558956
Introduction: Surgical resection is gold standard for treatment of liver metastasis, locally ablative techniques including computer tomography (CT)-guided interstitial high-dose-rate (HDR) brachytherapy (CT-BRT) and stereotactic body radiotherapy (SBRT) have gained...
6.
Bilski M, Konat-Baska K, Mastroleo F, Hoskin P, Jereczek-Fossa B, Marvaso G, et al.
Clin Transl Radiat Oncol
. 2024 Sep;
49:100845.
PMID: 39290455
Bone metastases (BMs) are the most common cause of cancer-related pain and radiation therapy plays a key role in treating pain caused by it. The half-body irradiation (HBI) is a...
7.
Kuncman L, Pajdzinski M, Smolka K, Bilski M, Socha J, Stando R, et al.
Front Immunol
. 2024 Aug;
15:1426635.
PMID: 39148729
Introduction: Radiation induced lymphopenia (RIL) deteriorate survival and diminishes the benefit of immune checkpoint inhibitors in combined treatment of lung cancer. Given the inconsistent data across various studies on the...
8.
Bilski M, Konat-Baska K, Zerella M, Corradini S, Hetnal M, Leonardi M, et al.
Radiat Oncol
. 2024 Aug;
19(1):103.
PMID: 39095859
Breast conserving treatment typically involves surgical excision of tumor and adjuvant radiotherapy targeting the breast area or tumor bed. Accurately defining the tumor bed is challenging and lead to irradiation...
9.
Santamaria R, Zaffaroni M, Vincini M, Colombi L, Gaeta A, Mastroleo F, et al.
Life (Basel)
. 2024 Jul;
14(7).
PMID: 39063623
Materials And Methods: Eighty-six patients who underwent SBRT for macroscopic bed recurrence after prostatectomy were retrospectively included. Patients were treated based on mpMRI or choline/PSMA PET. Results: The median time...
10.
Marvaso G, Vitullo A, Corrao G, Vincini M, Zaffaroni M, Villa R, et al.
Tumori
. 2024 May;
110(3):193-202.
PMID: 38726748
Aim: The study aims to report the feasibility and safety of palliative hypofractionated radiotherapy targeting macroscopic bladder tumors in a monocentric cohort of frail and elderly bladder cancer patients not...